Literature DB >> 27552410

Stereoscopic Viewing Can Induce Changes in the CA/C Ratio.

Pascaline Neveu1, Corinne Roumes1, Matthieu Philippe1, Philippe Fuchs2, Anne-Emmanuelle Priot3.   

Abstract

PURPOSE: Stereoscopic displays challenge the neural cross-coupling between accommodation and vergence by inducing a constant accommodative demand and a varying vergence demand. Stereoscopic viewing calls for a decrease in the gain of vergence accommodation, which is the accommodation caused by vergence, quantified by using the convergence-accommodation to convergence (CA/C) ratio. However, its adaptability is still a subject of debate.
METHODS: Cross-coupling (CA/C and AC/A ratios) and tonic components of vergence and accommodation were assessed in 12 participants (27.5 ± 5 years, stereoacuity better than 60 arc seconds, 6/6 acuity with corrected refractive error) before and after a 20-minute exposure to stereoscopic viewing. During stimulation, vergence demand oscillated from 1 to 3 meter angles along a virtual sagittal line in sinusoidal movements, while accommodative demand was fixed at 1.5 diopters.
RESULTS: Results showed a decreased CA/C ratio (-10.36%, df = 10, t = 2.835, P = 0.018), with no change in the AC/A ratio (P = 0.090), tonic vergence (P = 0.708), and tonic accommodation (P = 0.493).
CONCLUSIONS: These findings demonstrated that the CA/C ratio can exhibit adaptive adjustments. The observed nature and amount of the oculomotor modification failed to compensate for the stereoscopic constraint.

Entities:  

Mesh:

Year:  2016        PMID: 27552410     DOI: 10.1167/iovs.15-18854

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  1 in total

1.  Study of the Immediate Effects of Autostereoscopic 3D Visual Training on the Accommodative Functions of Myopes.

Authors:  Yangyi Huang; Meiyan Li; Yang Shen; Fang Liu; Yong Fang; Haipeng Xu; Xingtao Zhou
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-02-01       Impact factor: 4.799

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.